期刊文献+

红皮病型皮肤T细胞淋巴瘤六例

原文传递
导出
摘要 目的探讨红皮病型皮肤T细胞淋巴瘤(CTCL)的临床特点。方法回顾分析该院2006年5月至2009年3月收治的6例晚期CTCL患者的临床资料,并结合文献进行讨论。结果6例患者中男1例,女5例,平均年龄50岁,临床主要表现为皮肤瘙痒、弥漫潮红、脱屑、皲裂、渗出,起病初期全部诊断为皮肤疾病,病程中逐渐出现浅表淋巴结肿大,经病理确诊,从发病到确诊的时间为12。96个月,治疗主要包括外用药物和联合化疗,无一例达完全缓解,病情易复发或反复,且多局限于皮肤,3例并发严重感染,其中1例感染死亡,其余5例分别生存17—242个月。结论CTCL是少见的低恶度T细胞性淋巴瘤,确诊需病理学支持,晚期化疗效果欠佳,易并发感染,病情进展缓慢,生存期较长。
出处 《白血病.淋巴瘤》 CAS 2010年第1期49-50,共2页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献6

  • 1赵辩.临床皮肤病学.3版.南京:江苏科学技术出版社.2001:935-938.
  • 2Vonderheid EC, Bemengo MG, Burg G, et al. Update on erythrodemic cutaneous T-cell lymphoma: report of international society for cutaneous lymphomas. J Am Acad Dematol, 2002, 46: 95- 106.
  • 3Whittaker S. Biological insights into the pathogenesis of cutaneous T- cell lymphomas. Sere in Oncol, 2006, 33: S3-6.
  • 4李莹,袁卫如,郑捷,沈小雁.非化疗和化疗治疗皮肤T细胞淋巴瘤的临床疗效比较[J].临床皮肤科杂志,2008,37(2):91-93. 被引量:4
  • 5Dummer R, Cozzio A, Meier S, et al. Standard and experimental therapy in cutaneous T-cell lymphomas. J Cutan Pathol 2006, 33: 52-57.
  • 6Flink PR. Primary cutaneous lymphomas applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinieopathologic features observed in a large group of patients. Blood, 2002, 99: 800-805.

二级参考文献10

  • 1Kim E J, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma[J]. J Clin Invest, 2005, 115(4): 798-812.
  • 2Siegel RS, Pandolfino T, Guitart J, et al. Primary cutaneous Tcell lymphoma: review and current concepts [J]. J Clin Oncol, 2000, 18(15): 2908-2925.
  • 3Whittaker SJ, Marsden JR, Spittle M, et al. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas[J]. Br J Dermatol, 2003, 149(6): 1095-1107.
  • 4Kim YH, Liu HL, Mraz-Gemhard S, et al. Long-term outcome of 525 patients with mycosis fungoides and sezary syndrome: clinical prognostic factors and risk for disease progression [J]. Arch Dermatol, 2003, 139(7): 857-866.
  • 5Zackheim HS, Amin S, Kashani-Sabet M, et al. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients[J]. J Am Acad Dermatol, 1999, 40(3): 418-425.
  • 6Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma[J]. Blood, 2003, 101(9): 3407-3412.
  • 7Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105(10): 3768- 3785.
  • 8Duvie M, Apisurnthanarax N, Cohen DS, et al. Analysis of longterm outcomes of combined modality therapy for cutaneous Tcell lymphoma[J]. J Am Aead Dermatol, 2003, 49(1): 35-49.
  • 9Gettler SL, Fung MA. Efficacy of treatments for mycosis fungoides and Sezary syndrome:nationwide survey responses [J]. Dermatol Online J, 2005, 11(3): 6.
  • 10Zane C, Leali C, Airo P, et al. "High-dose" UVAI therapy of widespread plaque-type, nodular and erythrodermic mycosis fungoides[J]. J Am Acad Dermatol, 2001, 44(4): 629-633.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部